A new study released this week shows Dysport offers a significant efficacy advantage over the well-established Botox Cosmetic for treating crow’s feet. The study was presented during a scientific session at the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) 2010 Annual Fall Meeting.
Investigators studied 90 subjects, assessing contraction at 30 days following treatment when compared with day zero. The internally controlled, double-blind study found a greater efficacy of action for Dysport over Botox. "Botox has long been considered the gold standard of injectables, so this data showing Dysport’s stronger efficacy is compelling," says Corey D. Maas, MD, AAFPRS Group Vice President for Public and Regulatory Affairs.
The study concluded that Dysport offers a quantifiable and demonstrable advantage in wrinkle shortening and hyperfunctional frown lines compared to Botox Cosmetic in the treatment of crow’s feet. Study investigators recommend further studies in additional facial regions to confirm the data.
Downloadable photos, fact sheets and other supporting materials available here.
[Source: American Health & Beauty/Marketwire]